Wang Xiaobo, Zhang Zhaohui, Wu Zhangqiang, Sun Yuezong, Zhang Yili, Gong Ming, Ji Feng
Department of Gastroenterology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Department of Hepatobiliary and Pancreatic Surgery, Jinhua Hospital of Zhejiang University, Jinhua 321000, Zhejiang Province, China.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(3):375-382. doi: 10.3785/j.issn.1008-9292.2020.06.04.
To establish a clinical prediction model of the mid-term fatality risk after radical resection in patients with primary hepatocellular carcinoma (HCC) based on the albumin-bilirubin (ALBI) grade and to assess its prediction value.
Clinical data of 533 patients who received HCC radical resection in Jinhua Hospital of Zhejiang University, Jinhua People's Hospital, Jinhua Hospital of Traditional Chinese Medicine and Jinhua Guangfu Hospital from January 2010 to August 2016 were retrospectively reviewed. In the training group ( =407), Cox model was used to screen the clinical risk factors of postoperative death, and a predictive model based on ALBI grade was established and then examined in the validation group ( =126). The value of the prediction model was assessed by ROC curve and calibration curve; the prediction results of the model were visualized by the nomogram for the convenience of clinical use.
Cox model showed that ALT ≥ 80 U/L, tumor maximum diameter ≥ 5 cm, portal vein tumor thrombus and ALBI grade 2 were independent risk factors for the prognosis of patients with HCC radical resection. The prognosis index (PI) was 0.550×ALT+0.512×ALBI grade+0.872×maximum tumor diameter+1.377×portal vein tumor thrombus. The AUCs for predicting the risk of death in 12, 36 and 60 months were 0.872, 0.814 and 0.810, respectively (all < 0.01), and the goodness of fit ( ) of the established model were 0.953, 0.976 and 0.994. AUC of the established model for predicting risk of death in 36 months after resection was 0.814, which was higher than those of ALBI (AUC=0.683), BCLC (AUC=0.713), CLIP (AUC=0.689), Child-Pugh (AUC=0.645), TNM (AUC=0.612) ( < 0.05 or < 0.01).
ALT ≥ 80 U/L, maximum tumor diameter ≥ 5 cm, portal vein tumor thrombus and ALBI grade 2 are independent risk factors of patients after HCC resection, and ALBI grade-based prediction model is satisfactory in prediction of mid-term death risk of the patients.
基于白蛋白-胆红素(ALBI)分级建立原发性肝细胞癌(HCC)患者根治性切除术后中期死亡风险的临床预测模型,并评估其预测价值。
回顾性分析2010年1月至2016年8月在浙江大学金华医院、金华市人民医院、金华市中医医院和金华广福医院接受HCC根治性切除的533例患者的临床资料。在训练组(n = 407)中,采用Cox模型筛选术后死亡的临床危险因素,建立基于ALBI分级的预测模型,然后在验证组(n = 126)中进行检验。通过ROC曲线和校准曲线评估预测模型的价值;通过列线图将模型的预测结果可视化,以方便临床应用。
Cox模型显示,ALT≥80 U/L、肿瘤最大直径≥5 cm、门静脉癌栓和ALBI 2级是HCC根治性切除患者预后的独立危险因素。预后指数(PI)为0.550×ALT + 0.512×ALBI分级 + 0.872×肿瘤最大直径 + 1.377×门静脉癌栓。预测12、36和60个月死亡风险的AUC分别为0.872、0.814和0.810(均P < 0.01),所建立模型的拟合优度(Hosmer-Lemeshow检验)分别为0.953、0.976和0.994。所建立模型预测切除术后36个月死亡风险的AUC为0.814,高于ALBI(AUC = 0.683)、BCLC(AUC = 0.713)、CLIP(AUC = 0.689)、Child-Pugh(AUC = 0.645)、TNM(AUC = 0.612)(P < 0.05或P < 0.01)。
ALT≥80 U/L、肿瘤最大直径≥5 cm、门静脉癌栓和ALBI 2级是HCC切除术后患者的独立危险因素,基于ALBI分级的预测模型对患者中期死亡风险的预测效果良好。